The Philippines Blocks Sanofi's Dengue Vaccine for Safety Reasons

Share
The Philippines Blocks Sanofi's Dengue Vaccine for Safety Reasons

Brazil confirmed it already had recommended restricting use of the vaccine to those previously infected with dengue but had not suspended it entirely. The scare surrounding the disease, which upon infection can progress to progress to the deadly dengue haemorrhagic fever or dengue shock syndrome, has led scientists to develop the world's first ever dengue fever vaccine called the Dengvaxia vaccine. One such country, the Philippines, announced it would launch an investigation into the purchase of Sanofi's vaccine, and its Department of Health has put the vaccination program on hold.

Citing results of an assay test co-developed with the University of Pittsburgh, a Sanofi Pasteur India spokesperson told PTI, "For those not previously infected by dengue virus, the analysis found, in the longer term, more cases of severe disease could occur following vaccination upon a subsequent dengue infection".

Most sales have come from the Philippines through its government immunization program, and Brazil, where the state of Parana has seen a three-fold increase in dengue in the past few years.

"All drug establishments, including consumers and non-consumer user (e.g. healthcare professionals) are enjoined to take part in the post-marketing surveillance of Dengvaxia, by reporting to FDA any incident that reasonably indicates that Dengvaxia has caused or contributed to the death, serious illness, or serious injury to a consumer, a patient, or any person", the FDA said in a statement.

Anvisa did not immediately respond to a request for comment.

Sanofi, whose shares rose 0.4 percent in Paris on Monday, explained its "new findings" of increased risk at a news conference in Manila.

Former Health Secretary Janette Garin, who implemented the program under the administration of then-President Benigno Aquino, said she welcomed the investigation.

Volunteers Against Crime and Corruption, an NGO, said it was checking a report that three children on the northern island of Luzon had died since being vaccinated in April 2016 but the Department of Health said the deaths were not due to Dengvaxia.

Dengue is a mosquito-borne tropical disease that kills about 20,000 people a year and infects hundreds of millions. (WHO will now review Sanofi's safety data in more detail.) This followed an earlier warning that the vaccine should only be administered in countries where dengue is more than 50% prevalent.

Share

Advertisement

Related Posts

EPS Growth overview of Merck & Co., Inc. (NYSE:MRK)
Merck & Company, Inc.'s revenue was down 2.0% compared to the same quarter previous year . (NYSE MRK) opened at $56.22 on Tuesday. Segall Bryant And Hamill Ltd Limited Liability Company reported 0.48% of its portfolio in Parker-Hannifin Corporation (NYSE:PH).

Research Ratings: Tallgrass Energy Partners, LP (TEP), Fairmount Santrol Holdings Inc. (FMSA)
The Manufacturers Life Insurance Company grew its position in shares of Tallgrass Energy Partners by 7.2% during the 2nd quarter. Oppenheimer Asset Management has 0% invested in Oxford Industries, Inc. 90 were reported by Grp One Trading Limited Partnership.

Five centimetres of snow expected this weekend as forecasters issue weather warning
The warning states Storm Caroline is "expected to bring a spell of very windy weather to northern Scotland on Thursday". Scotland's mountain ranges, including the Cairngorms and Glen Coe, have already seen heavy snow falls in recent weeks.

UnitedHealth Group (NYSE:UNH) Shorted Shares Decreased By 9.03%
Zacks Investment Research cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Friday, May 19th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09.

McDonald's Is Back With 'Dollar' Menu; Price Wars Rage
The lineup, set to go live on January 4, includes items such as chicken tenders, sodas, triple cheeseburgers and the Egg McMuffin. According to the company, all of the value menus are created to protect franchisee margins.

Google Pixel 2 is now available at Rs. 39999 on Flipkart
To break the deal for you, Google Pixel 2 is getting a flat discount of Rs. 11,001, which brings down its price to Rs 49,999. Google Pixel 2 is the Google's latest Smartphone while the Pixel 2's price is terrifying the buyers.

AGF Investments America Inc. Purchases New Stake in NVIDIA Corporation (NASDAQ:NVDA)
The Ohio-based Public Employees Retirement Of Ohio has invested 0.01% in Benchmark Electronics, Inc. (NYSE:CLH) for 13,908 shares. Rampart Mgmt Ltd Llc holds 7,786 shares. 278.36 million shares or 0.37% less from 279.41 million shares in 2017Q1 were reported.

Boston Scientific (BSX) Upgraded by BTIG Research to "Buy"
Currently, 314.79 million total shares are owned by the public and among those 314.15 million shares have been available to trade. Sells 415,653 Shares of Boston Scientific Corporation (BSX )" was first published by Week Herald and is owned by of Week Herald.

Target's app pairs coupons with its credit card for faster checkouts
Folks will also be able to add their Target gift cards to Wallet, but again, the retailer did not say when that would be enabled. Both Target and Walmart are retailers who are part of CurrentC - a group of retailers with their own mobile payment solution.

Murphy Joins Cuomo, Brown to Condemn GOP Tax Plan
Some Democrats complained that the notes, which would presumably be part of the new federal tax law, weren't even legible. Cuomo said they would consider legal action to block the tax changes if the bill is approved.

© 2015 ExpressNewsline. All Rights reserved.